Infant formula

• US 5,013,569 A
• Filed: 05/21/1990
• Issued: 05/07/1991
• Est. Priority Date: 05/21/1990
• Status: Expired due to Fees

• Current Assignee: Century Laboratories, Inc. (Wolverine Holding Corp.)
• Original Assignee: Century Laboratories, Inc. (Wolverine Holding Corp.)
• Inventors: Rubin, David
• Primary Examiner(s): PADEN, CAROLYN A
• Application Number:
  US07/526,096
• Time in Patent Office: 351 Days
• Field of Search: 426/801, 426/585, 426/580
• US Class Current: 426/585
• CPC Class Codes: A23C 11/04 containing non-milk fats but no non-milk proteins A23C11/08, A23C11/10 take precedence
• CPC Class Codes: A23C 9/1528 Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
• CPC Class Codes: A23C 9/20 Dietetic milk products not covered by groups A23C9/12 - A23C9/18
• CPC Class Codes: Y10S 426/801 Pediatric

Abstract

An infant food formulation substantially approximating human milk in fatty acid composition comprising a mixture of DHA and EPA in a ratio of approximately 3:2 by weight, immunoglobulins to mimic the immunoglobulin content of mother'"'"'s milk, a source of protein, a source of carbohydrate, a source of ash, and sufficient water to provide an easily assimilable infant formula, the DHA, the EPA, and the immunoglobulins being encapsulated in capsules having a diameter of less than 350μ.

Claims

1. An infant food formulation substantially approximating human milk in fatty acid composition, comprising:

a mixture of 4,7,10,13,16,19-docosahexaenoic acid (DHA) and 5,8,11,14,17-eicosapentaenoic acid (EPA) in a ratio of approximately from 1;

1 to 2;

1 by weight, the EPA and DHA being present in a quantity substantially to mimic the relative quantity of fatty acid in human mother'"'"'s milk;

immunoglobulins in a quantity substantially to mimic the immunoglobulin content of human mother'"'"'s milk;

a source of protein in a quantity substantially to mimic the protein content of human mother'"'"'s milk;

a source of carbohydrate in a quantity substantially to mimic the carbohydrate content of human mother'"'"'s milk;

and sufficient water to provide an easily assimilable infant formula, said DHA and EPA and said immunoglobulins being microencapsulated.

2. The infant formula according to claim 1 wherein the DHA and EPA are in a ratio of approximately 3:

2 by weight.

3. The infant formula according to claim 1 wherein the EPA and DHA are in the free acids form thereof or in the form of a pharmaceutically acceptable salt thereof.

4. The infant formula according to claim 1 comprising from about 1-5% by weight of fat, from about 0.01 to about 3.0% by weight immunoglobulins, from about 4-10% by weight carbohydrate, from about 0.5 to 4% by weight protein, from about 0.1 to 1% by weight ash, a total solids content of about 8-17% by weight, and the remainder water.

5. The infant formula according to claim 4 comprising from about 1-5% by weight of fat, from about 0.01 to about 3.0% by weight immunoglobulins, from about 4-10% by weight carbohydrate, from about 0.5 to 4% by weight protein, a total solids content of about 8-17% by weight, and the remainder water.

6. A concentrate for preparing an infant food formulation substantially approximating human milk in fatty acid composition, comprising:

a mixture of DHA and EPA in a ratio of approximately from 1;

1 to 2;

1 by weight, the EPA and DHA being present in a quantity substantially mimicing the relative quantity of fatty acid in human mother'"'"'s milk;

immunoglobulins in a quantity substantially to mimic immunoglobulin content of human mother'"'"'s milk; and

a source of protein in a quantity substantially to mimic the protein content of human mother'"'"'s milk.